HAE has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Haemonetics Corp's total equity for the quarter that ended in Dec. 2013 was $825.2 Mil.
Total equity is used to calculate book value per share. Haemonetics Corp's book value per share for the quarter that ended in Dec. 2013 was $16.01. The ratio of a companys debt over equity can be used to measure how leveraged this company is. Haemonetics Corp's debt to equity ratio for the quarter that ended in Dec. 2013 was 0.54.
Total Equity refers to the net assets owned by shareholders.
Total Equity and Total Liabilities are the two components for Total Assets.
Haemonetics Corp's Total Equity for the fiscal year that ended in Mar. 2013 is calculated as
Haemonetics Corp's Total Equity for the quarter that ended in Dec. 2013 is calculated as
|=||Preferred Stock||+||Common Stock||+||Additional Paid-In Capital||+||Retained Earnings|
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
1. Total equity is used to calculate book value per share.
Haemonetics Corp's Book Value Per Share for the quarter that ended in Dec. 2013 is
|Book Value per Share||=||(Total Shareholders Equity||-||Preferred Stock)||/||Total Shares Outstanding|
2. The ratio of a companys debt over equity can be used to measure how leveraged this company is.
Haemonetics Corp's Debt to Equity Ratio for the quarter that ended in Dec. 2013 is
|Debt to Equity||=||Total Debt||/||Total Equity|
|=||(Current Portion of Long-Term Debt||+||Long-Term Debt)||/||Total Equity|
Total Assets, Total Liabilities, Preferred Stock, Common Stock, Retained Earnings, Treasury Stock, Book Value per Share, Total Shares Outstanding, Current Portion of Long-Term Debt, Long-Term Debt, Additional Paid-In Capital
Haemonetics Corp Annual Data
Haemonetics Corp Quarterly Data